Viracta Therapeutics, Inc. (VIRX) Reports In-Line Q1 EPS

Viracta Therapeutics, Inc. (NASDAQ: VIRX) reported Q1 EPS of ($0.32), in-line with the analyst estimate of ($0.32).

For earnings history and earnings-related data on Viracta Therapeutics, Inc. (VIRX) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• BioMarin to acquire Alesta Therapeutics for $275M upfront
• Eltek Ltd (ELTK) Reports Q2 EPS of $0.41